Viking Therapeutics, Inc.VKTXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+85.3%
5Y CAGR+61.0%
Year-over-Year Change
Research and development spending
3Y CAGR
+85.3%/yr
vs +29.9%/yr prior
5Y CAGR
+61.0%/yr
Recent acceleration
Acceleration
+55.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
10.8x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $344.95M | +239.4% |
| 2024 | $101.64M | +59.3% |
| 2023 | $63.81M | +17.6% |
| 2022 | $54.23M | +20.6% |
| 2021 | $44.98M | +40.9% |
| 2020 | $31.93M | +35.5% |
| 2019 | $23.56M | +23.7% |
| 2018 | $19.04M | +38.6% |
| 2017 | $13.74M | +52.7% |
| 2016 | $9.00M | - |